Literature DB >> 7490985

Evidence-based management of dyslipidaemia.

R Jackson1, R Beaglehole.   

Abstract

Mesh:

Year:  1995        PMID: 7490985     DOI: 10.1016/s0140-6736(95)92466-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

Authors:  D M Pickin; C J McCabe; L E Ramsay; N Payne; I U Haq; W W Yeo; P R Jackson
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Lipid screening in an elderly population: difficulty in interpretation and in detection of occult metabolic disease.

Authors:  A F Winder; C Jagger; D P Garrick; D T Vallance; P F Butowski; J Anderson; M Clarke
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

3.  A simple computer program for guiding management of cardiovascular risk factors and prescribing.

Authors:  A D Hingorani; P Vallance
Journal:  BMJ       Date:  1999-01-09

4.  Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk.

Authors:  J Michael Paterson; Hilary A Llewellyn-Thomas; C David Naylor
Journal:  Health Expect       Date:  2002-03       Impact factor: 3.377

Review 5.  Clinical positioning of HMG-CoA reductase inhibitors in lipid management protocols.

Authors:  M Cziraky
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 6.  Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease.

Authors:  K L Goa; L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

7.  Development of an experimental diet model in rats to study hyperlipidemia and insulin resistance, markers for coronary heart disease.

Authors:  Renuka P Munshi; Samidha G Joshi; Bhagyeshri N Rane
Journal:  Indian J Pharmacol       Date:  2014 May-Jun       Impact factor: 1.200

Review 8.  Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases.

Authors:  Ben van Steenkiste; Richard Grol; Trudy van der Weijden
Journal:  Vasc Health Risk Manag       Date:  2008
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.